Delivery Order SPE2DB25D3201-SPE2DB25FNSXA

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,743.82 firm-fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution 60ML, a prescription medication. The contract has a period of performance ending on September 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 60ml of Calcipotriene 0.005% Solution, a specialty medication. The contract has a firm fixed price of $4,183.67 and a completion date of May 17, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Calcipotriene 0.005% Solution 60ML. The contract has a firm fixed price and a ceiling value of $2,621.22. It is not a set-aside contract. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is for the delivery of Calcipotriene 0.005% Solution, a prescription medication. The contract has a completion date of April 7, 2025 and is a Firm Fixed Price contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Calcipotriene 0.005% Cream 60GM. The fixed-price contract has a ceiling value of $1,212.94 and a completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,738.26, is for the supply of 60ml bottles of Calcipotriene 0.005% solution, a topical medication used in the treatment of psoriasis. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,166.76 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% Cream in 60 gram quantities. The delivery order has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA for the provision of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,294.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% solution (60ml). This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,487.84 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution, a topical medication. The contract has an ultimate completion date of April 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $89,507.28, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565584311 - Calcipotriene 0.005% Cream 120GM. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNSXA
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568118638 - Calcipotriene 0.005% Solution 60ML. The contract has a ceiling value of $3,172.82 and a period of performance through May 5, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support services to military healthcare programs and other government agencies through December 2026. The contract is not designated as a set-aside.

Generated 8/3/25, 1:13 AM